Germany leads Europe's biotechnology research and experimental development sector with a turnover of 3.16 billion Euros in 2024, followed by the United Kingdom and France at 2.8 billion and 1.44 billion Euros respectively. Smaller markets like Poland and Austria show significant growth potential with year-on-year increases of 26.4% and 11.51% respectively. Norway's impressive 51.97% growth and Slovenia's 72.84% surge highlight emerging hotspots. The sector is buoyed by double-digit growth in countries like Spain, Italy, and Finland. Conversely, Belgium and Slovakia exhibit declines, indicating potential challenges.
Future trends to watch include continued robust growth in Nordic countries, bolstering of biotechnology hubs in Southern and Eastern Europe, and the potential for M&A activities and collaborations driven by smaller but rapidly growing markets like Norway and Slovenia. Regulatory harmonization and increased investment in innovation will be key drivers for sustained growth across Europe.
Top countries in Turnover of Biotechnology Research and Experimental Development by Country
| # | 10 Countries | Million Euros | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 3,160 | 2023 | +4.73% | +0.63% | View data |
| 2 | 2 United Kingdom | 2,800 | 2023 | +5.14% | +5.3% | View data |
| 3 | 3 France | 1,440 | 2023 | +1.73% | +4.62% | View data |
| 4 | 4 Belgium | 1,300 | 2023 | +10.82% | -0.51% | View data |
| 5 | 5 Spain | 1,140 | 2023 | +11.01% | +16.57% | View data |
| 6 | 6 Italy | 806 | 2023 | +7.88% | +8.97% | View data |
| 7 | 7 Denmark | 781.8 | 2023 | +4.5% | +4.85% | View data |
| 8 | 8 Norway | 775.7 | 2023 | +17.07% | +51.97% | View data |
| 9 | 9 Poland | 308.1 | 2023 | +14.37% | +26.4% | View data |
| 10 | 10 Austria | 300.4 | 2023 | +0.23% | +11.51% | View data |
